Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Centessa Pharmaceuticals (CNTA) Receivables - Other (2024 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Receivables - Other for 2 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Receivables - Other rose 1070.73% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, up 1070.73% year-over-year, with the annual reading at $3.4 million for FY2025, 1070.73% up from the prior year.
  • Receivables - Other for Q4 2025 was $3.4 million at Centessa Pharmaceuticals, up from $1.9 million in the prior quarter.
  • The five-year high for Receivables - Other was $3.4 million in Q4 2025, with the low at $287000.0 in Q4 2024.